Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Intervention Study to Evaluate the Impact of Treating gHAT Seropositives Subjects With Acoziborole on Transmission of T.b. Gambiense, and Obtain Further Safety Data on Acoziborole in gHAT Seropositives Individuals.

NCT07789743 is registered in ClinicalTrials.gov with Institute of Tropical Medicine, Belgium as lead sponsor.

NCT NCT07789743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07789743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Intervention Study to Evaluate the Impact of Treating gHAT Seropositives Subjects With Acoziborole on Transmission of T.b. Gambiense, and Obtain Further Safety Data on Acoziborole in gHAT Seropositives Individuals.
Lead sponsor
Institute of Tropical Medicine, Belgium
Phase
Phase 3
Overall status
Recruiting
Start date
March 15, 2024
Completion date
December 30, 2027
Enrollment
2,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

trypanosomiasis; african, due to trypanosoma brucei gambiense, gambiense